192 related articles for article (PubMed ID: 24160181)
1. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
Chakraborty S; Levenson AS; Biswas PK
BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.
Chakraborty S; Biswas PK
J Mol Model; 2014 Aug; 20(8):2338. PubMed ID: 25060147
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into the antagonistic action of diarylheptanoid on human estrogen receptor alpha.
Geetha Rani Y; Lakshmi BS
J Biomol Struct Dyn; 2019 Mar; 37(5):1189-1203. PubMed ID: 29557271
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
Greschik H; Flaig R; Renaud JP; Moras D
J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
Arao Y; Hamilton KJ; Coons LA; Korach KS
J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
[TBL] [Abstract][Full Text] [Related]
6. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach.
Puranik NV; Srivastava P; Bhatt G; John Mary DJS; Limaye AM; Sivaraman J
Sci Rep; 2019 May; 9(1):7450. PubMed ID: 31092862
[TBL] [Abstract][Full Text] [Related]
7. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
Celik L; Lund JD; Schiøtt B
Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
[TBL] [Abstract][Full Text] [Related]
8. In silico design of peptidic inhibitors targeting estrogen receptor alpha dimer interface.
Chakraborty S; Cole S; Rader N; King C; Rajnarayanan R; Biswas PK
Mol Divers; 2012 Aug; 16(3):441-51. PubMed ID: 22752657
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
Sakkiah S; Selvaraj C; Guo W; Liu J; Ge W; Patterson TA; Hong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502280
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
11. Ligand-selective interdomain conformations of estrogen receptor-alpha.
Padron A; Li L; Kofoed EM; Schaufele F
Mol Endocrinol; 2007 Jan; 21(1):49-61. PubMed ID: 17008385
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS
Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
14. Simulations reveal increased fluctuations in estrogen receptor-alpha conformation upon antagonist binding.
Ng HL
J Mol Graph Model; 2016 Sep; 69():72-7. PubMed ID: 27580485
[TBL] [Abstract][Full Text] [Related]
15. Characterization of agonist binding to His524 in the estrogen receptor α ligand binding domain.
Gao L; Tu Y; Ågren H; Eriksson LA
J Phys Chem B; 2012 Apr; 116(16):4823-30. PubMed ID: 22482773
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
[TBL] [Abstract][Full Text] [Related]
18. Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor α Ligand Binding Domain.
Arao Y; Korach KS
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366023
[TBL] [Abstract][Full Text] [Related]
19. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
Mueller SO; Simon S; Chae K; Metzler M; Korach KS
Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic activity of constituents from the rhizomes of Rheum undulatum Linné.
Park S; Kim YN; Kwak HJ; Jeong EJ; Kim SH
Bioorg Med Chem Lett; 2018 Feb; 28(4):552-557. PubMed ID: 29402747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
